Cowen Prime Advisors LLC - Q4 2022 holdings

$243 Thousand is the total value of Cowen Prime Advisors LLC's 192 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .

 Value Shares↓ Weighting
XGN ExitEXAGEN INC COMstock$0-500
-100.0%
-0.00%
COIN ExitCOINBASE GLOBAL INC COM CL Astock$0-250
-100.0%
-0.01%
ExitQUOTIENT LTD CALL$0-1,000
-100.0%
-0.01%
DRRX ExitDURECT CORP COMstock$0-128,187
-100.0%
-0.04%
RADA ExitRADA ELECTR INDS LTD COM PAR NEWstock$0-15,000
-100.0%
-0.08%
ExitQUIDELORTHO CORP COMstock$0-10,585
-100.0%
-0.44%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
PDF SOLUTIONS INC COM10Q2 202319.9%
ASPEN AEROGELS INC COM10Q2 20236.4%
FRANCHISE GROUP INC COM10Q2 20237.6%
ITERIS INC NEW COM10Q2 20236.3%
INSPIRED ENTMT INC COM10Q2 20236.0%
QUOTIENT TECHNOLOGY INC COM10Q2 202311.5%
HARMONIC INC COM10Q2 20234.5%
COMSCORE INC COM10Q2 20233.6%
SOCIETAL CDMO INC COM10Q2 20233.2%
DIGIMARC CORP NEW COM10Q2 20234.3%

View Cowen Prime Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Cowen Prime Advisors LLC Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ITERIS, INC.Sold outAugust 07, 202300.0%
PDF SOLUTIONS INCSold outAugust 07, 202300.0%
Societal CDMO, Inc.Sold outAugust 07, 202300.0%
HTG MOLECULAR DIAGNOSTICS, INCSold outFebruary 03, 202300.0%
NEPHROS INCSold outFebruary 03, 202300.0%

View Cowen Prime Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2023-08-07
SC 13G2023-08-07
SC 13G2023-08-07
13F-HR2023-07-31
13F-HR2023-05-03
SC 13G2023-02-03
SC 13G2023-02-03
SC 13G2023-02-03
SC 13G2023-02-03
SC 13G2023-02-03

View Cowen Prime Advisors LLC's complete filings history.

Compare quarters

Export Cowen Prime Advisors LLC's holdings